Metolazon Abcur (Metolazone)

Metolazone blocks the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney. This inhibition reduces reabsorption of sodium and chloride, leading to increased urinary loss of these ions together with water, which lowers blood volume and pressure and eases fluid overload.

The specific dose of Metolazon Abcur is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and laboratory values. Dosage adjustments are made individually; patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety data for metolazone in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To request Metolazon Abcur, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Metolazon Abcur belongs to the thiazide‑like diuretic class, offering potent natriuretic activity at lower doses compared with classic thiazides. It is often preferred when a stronger diuretic effect is needed, especially in patients with resistant hypertension or significant edema, while sharing a similar safety profile to other agents in its class.

Metolazon Abcur should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Metolazon Abcur is taken orally, usually with a glass of water. It may be prescribed with or without food, depending on the prescriber’s guidance. Patients should swallow the tablet whole and not crush or chew it unless specifically instructed.

The most serious risks include severe dehydration, electrolyte disturbances such as hypokalemia or hyponatremia, acute kidney injury, and rare allergic reactions that can cause rash, swelling or breathing difficulties. Prompt medical attention is required if any of these serious symptoms develop.

Metolazon Abcur should be avoided in individuals with known hypersensitivity to metolazone or other thiazide‑like diuretics, in patients with severe renal impairment, and in those who are taking lithium or digoxin without close monitoring. Clinicians must evaluate each patient’s medical history before prescribing.